151 Programs
-
Interview and Lecture
Exploring the Potential Role of PROTAC Estrogen Receptor Degraders in the Management of HR-Positive Metastatic Breast Cancer
-
-
E
-
E
-
-
E
-
E
-
-
Oncology Today with Dr Neil Love
Key Presentations from the 2025 ASCO Annual Meeting and the EHA 2025 Congress — Acute Myeloid Leukemia Edition
-
-
E
-
E
-
-
E
-
E
-
-
Oncology Today with Dr Neil Love
Optimizing the Integration of ADCs into the Treatment of HR-Positive and Triple-Negative Metastatic Breast Cancer
-
-
L
-
L
-
-
L
-
L
-
-
Oncology Today with Dr Neil Love
The Role of Oral Selective Estrogen Receptor Degraders in the Management of ER-Positive Metastatic Breast Cancer
-
-
P
-
P
-
-
P
-
P
-